Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem

Shio Shin Jean, Yu Tsang Lee, Su Mei Guo, Po Ren Hsueh

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We present a case of recurrent infection (infective spondilitis, psoas abscess, and bacteraemia) caused by a single strain of cefotaxime- and ciprofloxacin-resistant and bla CMY-2-containing Salmonella enterica serotype choleraesuis during a 4-month period in a patient with uremia. The patient was successfully treated with imipenem for 7 weeks. Our observation indicates that a carbapenem might be considered as a drug of choice for the treatment of infections caused by this emerging multi-resistant pathogen.

Original languageEnglish
JournalJournal of Infection
Volume51
Issue number3
DOIs
Publication statusPublished - Oct 2005
Externally publishedYes

Fingerprint

Salmonella enterica
Cefotaxime
Imipenem
Ciprofloxacin
Psoas Abscess
Carbapenems
Uremia
Bacteremia
Infection
Observation
Pharmaceutical Preparations
Serogroup
Therapeutics
beta-lactamase CMY-2

Keywords

  • Cefotaxime- and ciprofloxacin-resistant
  • Imipenem
  • Recurrent infection
  • Salmonella enterica serotype choleraesuis

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem. / Jean, Shio Shin; Lee, Yu Tsang; Guo, Su Mei; Hsueh, Po Ren.

In: Journal of Infection, Vol. 51, No. 3, 10.2005.

Research output: Contribution to journalArticle

@article{66a77443b27a4a52874705e9aa013e63,
title = "Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem",
abstract = "We present a case of recurrent infection (infective spondilitis, psoas abscess, and bacteraemia) caused by a single strain of cefotaxime- and ciprofloxacin-resistant and bla CMY-2-containing Salmonella enterica serotype choleraesuis during a 4-month period in a patient with uremia. The patient was successfully treated with imipenem for 7 weeks. Our observation indicates that a carbapenem might be considered as a drug of choice for the treatment of infections caused by this emerging multi-resistant pathogen.",
keywords = "Cefotaxime- and ciprofloxacin-resistant, Imipenem, Recurrent infection, Salmonella enterica serotype choleraesuis",
author = "Jean, {Shio Shin} and Lee, {Yu Tsang} and Guo, {Su Mei} and Hsueh, {Po Ren}",
year = "2005",
month = "10",
doi = "10.1016/j.jinf.2004.12.011",
language = "English",
volume = "51",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem

AU - Jean, Shio Shin

AU - Lee, Yu Tsang

AU - Guo, Su Mei

AU - Hsueh, Po Ren

PY - 2005/10

Y1 - 2005/10

N2 - We present a case of recurrent infection (infective spondilitis, psoas abscess, and bacteraemia) caused by a single strain of cefotaxime- and ciprofloxacin-resistant and bla CMY-2-containing Salmonella enterica serotype choleraesuis during a 4-month period in a patient with uremia. The patient was successfully treated with imipenem for 7 weeks. Our observation indicates that a carbapenem might be considered as a drug of choice for the treatment of infections caused by this emerging multi-resistant pathogen.

AB - We present a case of recurrent infection (infective spondilitis, psoas abscess, and bacteraemia) caused by a single strain of cefotaxime- and ciprofloxacin-resistant and bla CMY-2-containing Salmonella enterica serotype choleraesuis during a 4-month period in a patient with uremia. The patient was successfully treated with imipenem for 7 weeks. Our observation indicates that a carbapenem might be considered as a drug of choice for the treatment of infections caused by this emerging multi-resistant pathogen.

KW - Cefotaxime- and ciprofloxacin-resistant

KW - Imipenem

KW - Recurrent infection

KW - Salmonella enterica serotype choleraesuis

UR - http://www.scopus.com/inward/record.url?scp=27644474993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644474993&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2004.12.011

DO - 10.1016/j.jinf.2004.12.011

M3 - Article

VL - 51

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - 3

ER -